Donenberg Phillip B.
SEC CIK 1238120 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | Dir | 241.3K | $123.3K | — | 5 | 2022-02-02 | 2026-06-01 |
Most active insiders at TSHA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nagendran Sukumar | Pres, Head of R, D, Dir | — | $5.33M |
| 2 | Nolan Sean P. | CEO, Dir | — | $840.2K |
| 3 | Alam Kamran | CFO | — | $492.5K |
| 4 | Long Alison S | Dir | — | — |
| 5 | Sepp-Lorenzino Laura | Dir | — | — |
| 6 | Stalfort John A III | Dir | — | — |
| 7 | Donenberg Phillip B. | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-02 16:30 | 2026-06-01 | TSHA | Taysha Gene Therapies, Inc. | Donenberg Phillip B. | Dir | A - Grant | $0.00 | +21.3K | 241.3K | +10% | $0 |
| D | 2025-06-04 | 2025-06-02 | TSHA | Taysha Gene Therapies, Inc. | Donenberg Phillip B. | Dir | A - Grant | $0.00 | +56.6K | 220.0K | +35% | $0 |
| D | 2024-05-31 | 2024-05-29 | TSHA | Taysha Gene Therapies, Inc. | Donenberg Phillip B. | Dir | A - Grant | $0.00 | +49.2K | 163.3K | +43% | $0 |
| 2023-08-16 | 2023-08-16 | TSHA | Taysha Gene Therapies, Inc. | Donenberg Phillip B. | Dir | P - Purchase | $0.9 | +111.1K | 114.1K | +3,704% | +$100.0K | |
| 2022-02-03 | 2022-02-02 | TSHA | Taysha Gene Therapies, Inc. | Donenberg Phillip B. | Dir | P - Purchase | $7.78 | +3,000 | 3,000 | New | +$23.3K |
Purchase Sale Sale after option exercise All abbreviations